Liu Zhengtao, Lyu Jingting, Li Xiang, Yu Lu, Que Shuping, Xu Jun, Geng Lei, Zheng Shusen
Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China.
NHC Key Laboratory of Combined Multi-Organ Transplantation, Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, CAMS, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Front Surg. 2023 Jan 17;9:1075845. doi: 10.3389/fsurg.2022.1075845. eCollection 2022.
To investigate the interactions between the graft-to-recipient weight ratio (GWRWR) and other risk factors responsible for inferior allograft outcomes.
A total of 362 patients who received liver transplantation (LT) were enrolled. Indicators such as graft/recipient weight and other prognostic factors were collected. Comparisons of indicators and survival analysis were performed in groups categorized by the GWRWR. Interactions of large-for-size grafts (LFSGs) with graft macrosteatosis (MaS) were evaluated in terms of relative excess risk caused by interaction (RERI) and attributable proportion (AP). Cytoscape visualized the role of LFSGs in the risk profile for poor prognosis.
Based on the GWRWR, LT cases can be categorized into three subgroups, standard (1%-2.5%), optimal (2.5%-3.0%), and inferior prognosis (>3.0%). Survival analysis confirmed clear separations in cases categorized by the above-defined limits on the GWRWR ( < 0.05). LFSGs caused inferior prognosis by initiating positive interactions with MaS severity.
The GWRWR exerted nonlinear effects on prognosis in deceased donor LT cases. LFSGs (GWRWR > 3.0%) caused inferior outcomes, while grafts sized within (2.5%-3.0%) had optimal post-transplant prognosis. MaS increased the risk of poor prognosis by exerting positive synergistic effects on LFSGs.
研究移植物与受体重量比(GWRWR)与导致同种异体移植物预后不良的其他风险因素之间的相互作用。
共纳入362例接受肝移植(LT)的患者。收集移植物/受体重量等指标及其他预后因素。按GWRWR对患者分组,进行指标比较和生存分析。根据交互作用导致的相对超额风险(RERI)和归因比例(AP)评估大体积移植物(LFSG)与移植物大脂肪变(MaS)之间的相互作用。Cytoscape软件直观展示LFSG在预后不良风险谱中的作用。
根据GWRWR,LT病例可分为三个亚组,标准组(1%-2.5%)、最佳组(2.5%-3.0%)和预后不良组(>3.0%)。生存分析证实,按上述GWRWR定义的界限分组的病例有明显差异(P<0.05)。LFSG通过与MaS严重程度产生正向相互作用导致预后不良。
GWRWR对已故供体LT病例的预后有非线性影响。LFSG(GWRWR>3.0%)导致预后不良,而大小在(2.5%-3.0%)之间的移植物移植后预后最佳。MaS通过对LFSG产生正向协同作用增加预后不良风险。